Form D · Biotechnology
NEOTHERA BIOSCIENCES, INC.
Mountain View, CA · CIK 0001529514
Offering snapshot reported Sep 9, 2011 · SEC filing
- Reported sold
- $671K Offering amount: $671K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $10.5K Reported outside-investor minimum
- First sale
- Jun 24, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2011 | Initial | $671,417 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-165587
$550,000.00 paid in cash; $121,417.00 paid in conversion of Promissory Notes.
Source: Form D, filed Sep 9, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shirley Clayton | Director, Executive |
| Gary Johanning | Director |
| Bruce Keyt | Director, Executive |
| Feng Wang Johanning | Director |
| Dongxiao Zhang | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
320 Logue Ave.
Mountain View, CA, 94043
Mountain View, CA, 94043